Sarepta Therapeutics, Inc. (SRPT)
USD 51.38
(-5.6%)
USD 51.38
(-5.6%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.09 Billion USD | 37.83% |
| 2022 | 793.02 Million USD | 31.11% |
| 2021 | 604.83 Million USD | 26.88% |
| 2020 | 476.71 Million USD | 47.02% |
| 2019 | 324.24 Million USD | 21.51% |
| 2018 | 266.84 Million USD | 81.24% |
| 2017 | 147.23 Million USD | 2682.67% |
| 2016 | 5.29 Million USD | 103.65% |
| 2015 | -144.94 Million USD | -71.84% |
| 2014 | -84.34 Million USD | -10.89% |
| 2013 | -76.06 Million USD | -420.85% |
| 2012 | -14.6 Million USD | -232.01% |
| 2011 | 11.06 Million USD | 463.86% |
| 2010 | 1.96 Million USD | -88.84% |
| 2009 | 17.58 Million USD | -17.28% |
| 2008 | 21.25 Million USD | 93.52% |
| 2007 | 10.98 Million USD | 9428.23% |
| 2006 | 115.29 Thousand USD | -97.59% |
| 2005 | 4.78 Million USD | 1011.31% |
| 2004 | 430.46 Thousand USD | -55.62% |
| 2003 | 969.86 Thousand USD | 15.9% |
| 2002 | 836.78 Thousand USD | 18.51% |
| 2001 | 706.1 Thousand USD | -58.8% |
| 2000 | 1.71 Million USD | 1613.84% |
| 1999 | 100 Thousand USD | -75.0% |
| 1998 | 400 Thousand USD | -33.33% |
| 1997 | 600 Thousand USD | 0.0% |
| 1996 | 600 Thousand USD | 500.0% |
| 1995 | 100 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 362.9 Million USD | 2.92% |
| 2024 Q2 | 309.66 Million USD | -14.67% |
| 2023 Q2 | 227.11 Million USD | 3.95% |
| 2023 FY | 1.09 Billion USD | 37.83% |
| 2023 Q4 | 352.6 Million USD | 19.61% |
| 2023 Q1 | 218.48 Million USD | -4.02% |
| 2023 Q3 | 294.79 Million USD | 29.8% |
| 2022 FY | 793.02 Million USD | 31.11% |
| 2022 Q4 | 227.62 Million USD | 19.6% |
| 2022 Q3 | 190.31 Million USD | -2.75% |
| 2022 Q1 | 179.38 Million USD | 5.7% |
| 2022 Q2 | 195.69 Million USD | 9.09% |
| 2021 FY | 604.83 Million USD | 26.88% |
| 2021 Q1 | 124.58 Million USD | 1.51% |
| 2021 Q2 | 144.57 Million USD | 16.04% |
| 2021 Q3 | 165.96 Million USD | 14.79% |
| 2021 Q4 | 169.71 Million USD | 2.26% |
| 2020 Q3 | 128.9 Million USD | 3.94% |
| 2020 Q2 | 124.02 Million USD | 22.73% |
| 2020 FY | 476.71 Million USD | 47.02% |
| 2020 Q1 | 101.05 Million USD | 19.52% |
| 2020 Q4 | 122.73 Million USD | -4.79% |
| 2019 Q4 | 84.54 Million USD | -1.7% |
| 2019 Q2 | 78.74 Million USD | 5.07% |
| 2019 Q3 | 86 Million USD | 9.21% |
| 2019 Q1 | 74.94 Million USD | 5.15% |
| 2019 FY | 324.24 Million USD | 21.51% |
| 2018 Q2 | 66.79 Million USD | 13.17% |
| 2018 FY | 266.84 Million USD | 81.24% |
| 2018 Q4 | 71.28 Million USD | 2.2% |
| 2018 Q3 | 69.74 Million USD | 4.42% |
| 2018 Q1 | 59.02 Million USD | 9.85% |
| 2017 Q4 | 53.73 Million USD | 25.32% |
| 2017 FY | 147.23 Million USD | 2682.67% |
| 2017 Q1 | 16.09 Million USD | 204.1% |
| 2017 Q2 | 34.47 Million USD | 114.28% |
| 2017 Q3 | 42.87 Million USD | 24.36% |
| 2016 Q3 | -33.57 Million USD | 23.4% |
| 2016 FY | 5.29 Million USD | 103.65% |
| 2016 Q1 | -38.32 Million USD | 4.01% |
| 2016 Q4 | 5.29 Million USD | 115.76% |
| 2016 Q2 | -43.83 Million USD | -14.39% |
| 2015 Q3 | -36.67 Million USD | -25.68% |
| 2015 FY | -144.94 Million USD | -71.84% |
| 2015 Q1 | -61.86 Million USD | -101.66% |
| 2015 Q2 | -29.18 Million USD | 52.83% |
| 2015 Q4 | -39.92 Million USD | -8.87% |
| 2014 FY | -84.34 Million USD | -10.89% |
| 2014 Q2 | -27.68 Million USD | -45.47% |
| 2014 Q1 | -19.03 Million USD | 11.62% |
| 2014 Q3 | -32.61 Million USD | -17.8% |
| 2014 Q4 | -30.67 Million USD | 5.94% |
| 2013 Q2 | -14.13 Million USD | -57.28% |
| 2013 Q1 | -8.98 Million USD | -66.51% |
| 2013 Q3 | -20.76 Million USD | -46.89% |
| 2013 Q4 | -21.53 Million USD | -3.71% |
| 2013 FY | -76.06 Million USD | -420.85% |
| 2012 Q3 | 669 Thousand USD | -88.16% |
| 2012 FY | -14.6 Million USD | -232.01% |
| 2012 Q2 | 5.65 Million USD | 30.24% |
| 2012 Q1 | 4.33 Million USD | -68.07% |
| 2012 Q4 | -5.39 Million USD | -906.88% |
| 2011 Q2 | 11.58 Million USD | 32.17% |
| 2011 FY | 11.06 Million USD | 463.86% |
| 2011 Q3 | -3.74 Million USD | -132.34% |
| 2011 Q4 | 13.58 Million USD | 462.56% |
| 2011 Q1 | 8.76 Million USD | 173.4% |
| 2010 Q3 | 4.9 Million USD | 233.65% |
| 2010 Q2 | -3.67 Million USD | 43.8% |
| 2010 Q1 | -6.53 Million USD | -227.02% |
| 2010 Q4 | -11.94 Million USD | -343.45% |
| 2010 FY | 1.96 Million USD | -88.84% |
| 2009 Q3 | 3.42 Million USD | 16.3% |
| 2009 FY | 17.58 Million USD | -17.28% |
| 2009 Q1 | 3.15 Million USD | -42.52% |
| 2009 Q2 | 2.94 Million USD | -6.51% |
| 2009 Q4 | 5.14 Million USD | 50.1% |
| 2008 Q4 | 5.47 Million USD | 5.98% |
| 2008 FY | 21.25 Million USD | 93.52% |
| 2008 Q2 | 4.98 Million USD | -11.41% |
| 2008 Q1 | 5.62 Million USD | 8.45% |
| 2008 Q3 | 5.17 Million USD | 3.77% |
| 2007 Q3 | 2.91 Million USD | 23.81% |
| 2007 Q1 | 536.04 Thousand USD | 2959.78% |
| 2007 FY | 10.98 Million USD | 9428.23% |
| 2007 Q4 | 5.18 Million USD | 78.14% |
| 2007 Q2 | 2.35 Million USD | 338.66% |
| 2006 Q3 | 13.25 Thousand USD | -28.59% |
| 2006 Q2 | 18.55 Thousand USD | -71.87% |
| 2006 Q1 | 65.96 Thousand USD | -95.35% |
| 2006 FY | 115.29 Thousand USD | -97.59% |
| 2006 Q4 | 17.51 Thousand USD | 32.2% |
| 2005 Q1 | 45.19 Thousand USD | -84.18% |
| 2005 Q4 | 1.41 Million USD | -56.81% |
| 2005 Q3 | 3.28 Million USD | 8247.04% |
| 2005 Q2 | 39.31 Thousand USD | -13.0% |
| 2005 FY | 4.78 Million USD | 1011.31% |
| 2004 Q1 | 99.45 Thousand USD | -26.43% |
| 2004 Q3 | 9151.00 USD | -74.77% |
| 2004 Q4 | 285.58 Thousand USD | 3020.84% |
| 2004 Q2 | 36.27 Thousand USD | -63.53% |
| 2004 FY | 430.46 Thousand USD | -55.62% |
| 2003 Q3 | 414.35 Thousand USD | 155.13% |
| 2003 Q2 | 162.41 Thousand USD | -37.03% |
| 2003 Q1 | 257.92 Thousand USD | 52.43% |
| 2003 FY | 969.86 Thousand USD | 15.9% |
| 2003 Q4 | 135.18 Thousand USD | -67.38% |
| 2002 Q4 | 169.2 Thousand USD | -27.13% |
| 2002 Q1 | 237.69 Thousand USD | -19.51% |
| 2002 Q2 | 197.69 Thousand USD | -16.83% |
| 2002 Q3 | 232.19 Thousand USD | 17.45% |
| 2002 FY | 836.78 Thousand USD | 18.51% |
| 2001 Q3 | 307.54 Thousand USD | 252.44% |
| 2001 Q1 | 15.98 Thousand USD | -92.26% |
| 2001 Q2 | 87.26 Thousand USD | 446.08% |
| 2001 Q4 | 295.3 Thousand USD | -3.98% |
| 2001 FY | 706.1 Thousand USD | -58.8% |
| 2000 FY | 1.71 Million USD | 1613.84% |
| 2000 Q2 | 94.22 Thousand USD | -92.18% |
| 2000 Q1 | 1.2 Million USD | 0.0% |
| 2000 Q3 | 208.69 Thousand USD | 121.5% |
| 2000 Q4 | 206.32 Thousand USD | -1.13% |
| 1999 Q4 | - USD | -100.0% |
| 1999 FY | 100 Thousand USD | -75.0% |
| 1999 Q1 | 200 Thousand USD | 100.0% |
| 1999 Q3 | 200 Thousand USD | 100.0% |
| 1999 Q2 | 100 Thousand USD | -50.0% |
| 1998 Q2 | 200 Thousand USD | 0.0% |
| 1998 Q3 | 200 Thousand USD | 0.0% |
| 1998 FY | 400 Thousand USD | -33.33% |
| 1998 Q4 | 100 Thousand USD | -50.0% |
| 1998 Q1 | 200 Thousand USD | 0.0% |
| 1997 Q1 | 200 Thousand USD | 1900.0% |
| 1997 Q3 | 100 Thousand USD | -66.67% |
| 1997 FY | 600 Thousand USD | 0.0% |
| 1997 Q4 | 200 Thousand USD | 100.0% |
| 1997 Q2 | 300 Thousand USD | 50.0% |
| 1996 Q3 | 20 Thousand USD | 0.0% |
| 1996 FY | 600 Thousand USD | 500.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q4 | 10 Thousand USD | -50.0% |
| 1996 Q2 | - USD | 0.0% |
| 1995 FY | 100 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -2774.406% |
| Alkermes plc | 1.37 Billion USD | 20.491% |
| Agenus Inc. | 139.61 Million USD | -682.862% |
| Aptorum Group Limited | -1.11 Million USD | 98153.715% |
| Ardelyx, Inc. | 106.66 Million USD | -924.735% |
| Dyadic International, Inc. | 922.95 Thousand USD | -118322.96% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -5089.654% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 625228.258% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 8282.403% |
| Novavax, Inc. | 639.93 Million USD | -70.797% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 2433.511% |
| Pyxis Oncology, Inc. | -2 Million USD | 54749.65% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 211614.555% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -5639.605% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 2473606.382% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 207499.051% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 1212.835% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -136183.416% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1333018.293% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -708.014% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -13786.33% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 1227.378% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 27.992% |
| AlloVir, Inc. | -398 Thousand USD | 274721.357% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -354.023% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -257681.368% |
| Bicycle Therapeutics plc | -129.52 Million USD | 943.88% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -910727.5% |
| ChromaDex Corporation | 50.78 Million USD | -2052.408% |
| Chimerix, Inc. | 324 Thousand USD | -337243.519% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 3606.818% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 1508.532% |
| CRISPR Therapeutics AG | 240.95 Million USD | -353.607% |
| Precision BioSciences, Inc. | 40.47 Million USD | -2600.615% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 1213.447% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1789.259% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1789.259% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -6493.431% |
| ImmuCell Corporation | 4.39 Million USD | -24761.747% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 1129.93% |
| Immix Biopharma, Inc. | -5468.00 USD | 19988999.049% |
| Incyte Corporation | 3.44 Billion USD | 68.233% |
| Innoviva, Inc. | 261.06 Million USD | -318.667% |
| IO Biotech, Inc. | -756 Thousand USD | 144675.794% |
| Jaguar Health, Inc. | 7.72 Million USD | -14050.608% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 164707.38% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -812.706% |
| ContextLogic Inc. | 59 Million USD | -1752.531% |
| MiMedx Group, Inc. | 266.84 Million USD | -309.602% |
| MEI Pharma, Inc. | 49.32 Million USD | -2115.811% |
| NextCure, Inc. | -3.68 Million USD | 29768.648% |
| Onconetix, Inc. | -1.12 Million USD | 97068.323% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 3873.105% |
| Opthea Limited | 21.72 Thousand USD | -5032096.133% |
| Psyence Biomedical Ltd. | -240.00 USD | 455413850.0% |
| Vaxcyte, Inc. | -75 Million USD | 1557.324% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 1906727.01% |
| Precigen, Inc. | 106 Thousand USD | -1031025.472% |
| Pharming Group N.V. | 220.1 Million USD | -396.58% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -212131.65% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -108224.381% |
| PureTech Health plc | -1.6 Million USD | 68284.217% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -895.694% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 702.505% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 2511.457% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 5071.087% |
| Acelyrin, Inc. | -115 Thousand USD | 950528.696% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 10874570.202% |
| Summit Therapeutics Inc. | -2.05 Million USD | 53416.732% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 191517.338% |
| Senti Biosciences, Inc. | -2.68 Million USD | 40837.719% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -26880.82% |
| Elevation Oncology, Inc. | -39 Thousand USD | 2802646.154% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 22880.179% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 27826.527% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -3652.25% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -220261.492% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 1987360.0% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -949.955% |
| Seer, Inc. | 7.02 Million USD | -15454.191% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -24865.578% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -4973.07% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 922527.02% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 762825.312% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -179373.399% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -807.244% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -248.451% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 21859960.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -42362.821% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 2154205.242% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -3619.308% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 471217.672% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 222253.049% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 15498.605% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 230424.416% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 10509648.077% |
| Soligenix, Inc. | 97.31 Thousand USD | -1123095.733% |
| Century Therapeutics, Inc. | -10.8 Million USD | 10211.879% |
| Kura Oncology, Inc. | -849 Thousand USD | 128838.869% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 1728.805% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 743632.653% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1003.599% |
| Autolus Therapeutics plc | -4.86 Million USD | 22557.222% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -2540.973% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 650691.071% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -1053.883% |
| GRI Bio, Inc. | 10.84 Million USD | -9982.031% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -42931.458% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 12681.939% |
| IGM Biosciences, Inc. | -211.66 Million USD | 616.391% |
| INmune Bio, Inc. | 155 Thousand USD | -705056.774% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -1664.628% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 72661.875% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 168653.668% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 3733764.685% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -271788.806% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 54859.168% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 349299.042% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -1057.084% |
| Verastem, Inc. | -62 Thousand USD | 1762991.935% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -44786.776% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 418871.264% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -36008.127% |
| Histogen Inc. | 3.76 Million USD | -28899.549% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -189596.778% |
| Surrozen, Inc. | -27.23 Million USD | 4113.929% |
| Organovo Holdings, Inc. | -5.38 Million USD | 20381.926% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 90813.847% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 4361.68% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -5350.793% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 55201766.667% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -17917.092% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 1628249.439% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -606.109% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -749552.263% |
| Apollomics, Inc. | 127 Thousand USD | -860524.409% |
| Amarin Corporation plc | 165.54 Million USD | -560.255% |
| Mesoblast Limited | -9.81 Million USD | 11235.945% |
| Turnstone Biologics Corp. | 16.5 Million USD | -6521.792% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1089.232% |
| Synaptogenix, Inc. | -6347.00 USD | 17220723.917% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 2143223.529% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -577.342% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 37.815% |
| Better Therapeutics, Inc. | -2.72 Million USD | 40151.044% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1074.486% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -223.293% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 9581034.432% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 17559.952% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 98745.578% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -14835.677% |
| Insmed Incorporated | 239.63 Million USD | -356.107% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -30447.596% |
| OmniAb, Inc. | 14.66 Million USD | -7352.056% |
| Alector, Inc. | -95.05 Million USD | 1249.877% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -770.072% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 2614.767% |
| Zai Lab Limited | 170.9 Million USD | -539.54% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -1234.921% |
| Aura Biosciences, Inc. | -1.29 Million USD | 84501.004% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -840663.846% |
| Immunic, Inc. | -111 Thousand USD | 984778.378% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -6794.115% |
| Veracyte, Inc. | 248.14 Million USD | -340.46% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 115.639% |
| FibroGen, Inc. | 128.9 Million USD | -747.912% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 193793185.106% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 9468.336% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 67.84% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -280875.064% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -207.586% |
| TG Therapeutics, Inc. | 219.1 Million USD | -398.838% |
| Galecto, Inc. | -830 Thousand USD | 131785.904% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 79016.462% |
| Fortrea Holdings Inc. | 424 Million USD | -157.781% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 1368.459% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 192867.725% |
| XBiotech Inc. | -1.74 Million USD | 62771.617% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 98745.578% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 2451.989% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 1547.021% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -1389.03% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -6404.749% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -180.946% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 2301.529% |
| Vaxxinity, Inc. | -2.23 Million USD | 49025.38% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -234.503% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 9752.139% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -4370.136% |
| NexImmune, Inc. | -1.02 Million USD | 106736.376% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -20240511.111% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 15482.014% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 90.329% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 1635655.988% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 30879.865% |
| Ainos, Inc. | -253.73 Thousand USD | 430865.017% |
| Pluri Inc. | 322 Thousand USD | -339338.82% |
| Prothena Corporation plc | -129.2 Million USD | 945.963% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -2067.607% |
| Celularity Inc. | 6.75 Million USD | -16080.503% |
| Rallybio Corporation | -150 Thousand USD | 728762.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 3452.02% |
| MeiraGTx Holdings plc | 287 Thousand USD | -380733.798% |
| Omeros Corporation | -69.77 Million USD | 1666.364% |
| Humacyte, Inc. | -76.55 Million USD | 1527.816% |
| Immunocore Holdings plc | 248.39 Million USD | -340.029% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 7305.439% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -1652.097% |
| Blueprint Medicines Corporation | 236.58 Million USD | -361.989% |
| CalciMedica, Inc. | -58 Thousand USD | 1884570.69% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 76747.475% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -3661.807% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 38531.54% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 3641.205% |
| Pulmatrix, Inc. | -8.22 Million USD | 13396.752% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 93518.205% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 274033.083% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 374.075% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -39278.834% |
| Cytokinetics, Incorporated | -322.59 Million USD | 438.815% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -126681.889% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 320625.806% |
| Vor Biopharma Inc. | -3.49 Million USD | 31399.914% |
| Roivant Sciences Ltd. | 109.23 Million USD | -900.589% |
| Evogene Ltd. | 1.39 Million USD | -78026.733% |
| ProKidney Corp. | -3.16 Million USD | 34590.155% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 2589.053% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -15839.813% |
| CorMedix Inc. | -205.56 Thousand USD | 531809.655% |
| BioLineRx Ltd. | 1.1 Million USD | -98545.578% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 1489.321% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 3312200.0% |
| Atai Life Sciences N.V. | -5000.00 USD | 21859960.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 897032.52% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 1138634.375% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 78789.201% |
| Sagimet Biosciences Inc. | 2 Million USD | -54549.65% |
| MediciNova, Inc. | 979.7 Thousand USD | -111463.481% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 1396.259% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1156033.584% |
| GeoVax Labs, Inc. | -20.72 Million USD | 5374.868% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -346.968% |
| Biomea Fusion, Inc. | -4.2 Million USD | 26117.448% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -25.295% |
| Mereo BioPharma Group plc | 7.42 Million USD | -14618.462% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 352678.387% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 9108375.0% |
| Absci Corporation | -41.84 Million USD | 2711.754% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 21859960.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 1531.125% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 44512.556% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -411.378% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 116252.285% |
| Allakos Inc. | -6.14 Million USD | 17898.29% |
| Imunon, Inc. | -720 Thousand USD | 151903.529% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 1684.14% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -129.672% |
| BioAtla, Inc. | -103.73 Million USD | 1153.68% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 9581034.432% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 614141.011% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 550.127% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 351544.695% |
| XOMA Corporation | 3.86 Million USD | -28208.547% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 1659.525% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -7288.083% |
| aTyr Pharma, Inc. | -2.38 Million USD | 45870.226% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -8672.014% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 3769041.379% |
| Viridian Therapeutics, Inc. | -1 Million USD | 108531.845% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -8407638361.538% |
| Akari Therapeutics, Plc | -4000.00 USD | 27324925.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -71.614% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -561249.816% |
| UroGen Pharma Ltd. | 73.35 Million USD | -1390.066% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 4194.527% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -9414137.726% |
| Orgenesis Inc. | -5.72 Million USD | 19191.581% |
| Entera Bio Ltd. | -56 Thousand USD | 1951873.214% |
| GH Research PLC | -315 Thousand USD | 347081.905% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 578403.175% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 208289.143% |
| Xencor, Inc. | -85.26 Million USD | 1381.953% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 494718.444% |
| Replimune Group, Inc. | -2.65 Million USD | 41267.345% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 109264.373% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -514.58% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -561249.816% |
| Portage Biotech Inc. | -54 Thousand USD | 2024161.111% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1156033.584% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 290018.568% |
| OncoCyte Corporation | 413 Thousand USD | -264547.215% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 24315850.834% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 492339289.189% |
| Purple Biotech Ltd. | -196 Thousand USD | 557749.49% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -12087.701% |
| scPharmaceuticals Inc. | 9.78 Million USD | -11073.513% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 10564.313% |
| HilleVax, Inc. | -2.15 Million USD | 50795.408% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 1126896.907% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 7284777.419% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 163721.707% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 4752243.478% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 14561380.335% |
| Savara Inc. | -44.26 Million USD | 2569.371% |
| Curis, Inc. | 9.81 Million USD | -11040.485% |
| Daré Bioscience, Inc. | 2.76 Million USD | -39365.041% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 875979.892% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 63315.327% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 479482.895% |
| BeiGene, Ltd. | 2.07 Billion USD | 47.423% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 39192.707% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 373.478% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -1828.085% |
| Erasca, Inc. | -3.73 Million USD | 29387.058% |
| bluebird bio, Inc. | -4.03 Million USD | 27221.414% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 3873489.326% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 42.606% |
| DBV Technologies S.A. | 15.72 Million USD | -6849.345% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 3873489.326% |
| Moderna, Inc. | 2.15 Billion USD | 49.281% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 119552.787% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -13552.173% |
| Molecular Templates, Inc. | 50.39 Million USD | -2068.852% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 204016.604% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -716.959% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 17666.586% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 2878.113% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1083.544% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 30562.458% |
| MacroGenics, Inc. | 50.52 Million USD | -2063.186% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 18023.795% |
| Prime Medicine, Inc. | -147.9 Million USD | 838.983% |
| Aditxt, Inc. | -111.66 Thousand USD | 978958.141% |
| Adagene Inc. | 18.11 Million USD | -5934.804% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -223873.975% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -679.584% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -592.487% |
| SciSparc Ltd. | 2.19 Million USD | -49671.995% |
| Vericel Corporation | 135.57 Million USD | -706.185% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 4363519.697% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 3527932.29% |
| Generation Bio Co. | -73.91 Million USD | 1578.796% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 250212.815% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -1901.122% |
| Invivyd, Inc. | -2.02 Million USD | 53995.118% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 463.313% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 1056764.862% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -1034.187% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -1012.031% |
| ADMA Biologics, Inc. | 88.21 Million USD | -1138.968% |
| Clene Inc. | 533 Thousand USD | -204964.353% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -4433.513% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 114310.345% |
| GeoVax Labs, Inc. | -20.72 Million USD | 5374.868% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -54879.527% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 562582.245% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -2094.545% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 15511.633% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 130840.789% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -1210.307% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -1494857.052% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -1955.967% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 731.102% |
| Trevena, Inc. | 1.45 Million USD | -75019.794% |
| Surrozen, Inc. | -27.23 Million USD | 4113.929% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 309729.745% |
| Cingulate Inc. | -582.91 Thousand USD | 187603.731% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 3525883.871% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 5648.469% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 14438580.845% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 124162.77% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -60.568% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 110726.822% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 1940025.81% |
| Kronos Bio, Inc. | 1.37 Million USD | -79564.213% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 2136.658% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 374412.671% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 223929.954% |
| ImmunityBio, Inc. | -17.89 Million USD | 6209.519% |
| Korro Bio, Inc. | -3.63 Million USD | 30210.0% |
| Kineta, Inc. | 5.43 Million USD | -20017.67% |
| BioVie Inc. | -229.37 Thousand USD | 476605.055% |
| Codexis, Inc. | 57.33 Million USD | -1806.361% |
| Celularity Inc. | 6.75 Million USD | -16080.503% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -27136.307% |
| Celcuity Inc. | -142.77 Thousand USD | 765651.369% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -2160392.192% |
| Cibus, Inc. | 1.42 Million USD | -76763.08% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 292344.118% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 4868.938% |
| IN8bio, Inc. | -2.5 Million USD | 43802.239% |
| Kodiak Sciences Inc. | -25.94 Million USD | 4312.406% |
| Annexon, Inc. | -3.26 Million USD | 33555.556% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 53573.239% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 2718.763% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -170680.156% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -40.395% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -531.952% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 57625.947% |
| Arcellx, Inc. | 108.27 Million USD | -909.423% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 3476.666% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -1279.972% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 5267.327% |
| Moolec Science SA | -143.3 Thousand USD | 762804.023% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 2682.809% |
| Geron Corporation | -123.5 Million USD | 984.993% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -33151.993% |
| Royalty Pharma plc | 1.79 Billion USD | 39.072% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 1659.414% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 30260149.834% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -472257.611% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1081.019% |
| Humacyte, Inc. | -76.55 Million USD | 1527.816% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 115252.016% |
| 89bio, Inc. | -273 Thousand USD | 400463.736% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 87052.506% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 128990.684% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 888712.195% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -97575.871% |
| Notable Labs, Ltd. | 113 Thousand USD | -967150.442% |
| Liquidia Corporation | 14.6 Million USD | -7386.253% |
| Mustang Bio, Inc. | -2.22 Million USD | 49223.281% |
| Immunovant, Inc. | -231 Thousand USD | 473257.143% |
| Quantum-Si incorporated | 488 Thousand USD | -223873.975% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 2067.265% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 3643410.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -58599.946% |
| Acasti Pharma Inc. | -11 Thousand USD | 9936400.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 534265.294% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 168653.668% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 752.486% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -96234.591% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 286974.803% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 55921.91% |
| PepGen Inc. | -1.18 Million USD | 92413.598% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 860724.409% |
| United Therapeutics Corporation | 2.07 Billion USD | 47.198% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 4873.521% |
| Solid Biosciences Inc. | -76.56 Million USD | 1527.573% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 1323608.47% |
| Immuneering Corporation | -764.13 Thousand USD | 143136.075% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -1649352.191% |
| Belite Bio, Inc | -399 Thousand USD | 274033.083% |
| XOMA Corporation | 3.86 Million USD | -28208.547% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 5555.146% |
| Bionomics Limited | -434.44 Thousand USD | 251681.428% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 101868.436% |
| uniQure N.V. | 2.21 Million USD | -49245.056% |
| Cassava Sciences, Inc. | -89.42 Million USD | 1322.273% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 1287.146% |
| Forte Biosciences, Inc. | -9000.00 USD | 12144466.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 130997.365% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 250212.815% |
| Altimmune, Inc. | -65.37 Million USD | 1771.933% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -201.907% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 101868.436% |
| Compugen Ltd. | 31.45 Million USD | -3374.783% |
| Peak Bio, Inc. | 367.76 Thousand USD | -297095.522% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -4358.284% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1011930.556% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 1401373.077% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 90955.611% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 60088.639% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 918581.513% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 90955.611% |
| Instil Bio, Inc. | -4.75 Million USD | 23081.35% |
| argenx SE | 1.1 Billion USD | 1.397% |
| Immunome, Inc. | -8.9 Million USD | 12371.169% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 57930.317% |
| Verona Pharma plc | -679.62 Thousand USD | 160923.19% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 624667.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 45927.799% |
| CervoMed Inc. | -1.29 Million USD | 84590.583% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 45508.932% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 22980.322% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -44132.821% |
| Moolec Science SA | -143.3 Thousand USD | 762804.023% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 267970.745% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 41012.654% |
| AnaptysBio, Inc. | 14.78 Million USD | -7294.581% |
| Design Therapeutics, Inc. | -537 Thousand USD | 203636.872% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 256070.258% |
| NeurAxis, Inc. | 2.15 Million USD | -50578.86% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -50831.64% |
| Lumos Pharma, Inc. | 2 Million USD | -54359.043% |
| Achilles Therapeutics plc | -4.73 Million USD | 23201.486% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 624667.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1034396.664% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -3352.42% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -126681.889% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 106010.174% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 2499.651% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -2541744.186% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 133067.518% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 8306780.347% |
| Palisade Bio, Inc. | 246 Thousand USD | -444206.098% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 3312200.0% |
| Beam Therapeutics Inc. | -59.67 Million USD | 1931.668% |
| Neurogene Inc. | -3.26 Million USD | 33606.836% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -684.435% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 29704.361% |
| Sesen Bio, Inc. | 40 Million USD | -2632.483% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 368111.111% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 27241.37% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 11525.81% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -7662.734% |
| Athira Pharma, Inc. | -969 Thousand USD | 112895.975% |
| Vaccinex, Inc. | -16 Million USD | 6929.499% |
| HCW Biologics Inc. | -574.82 Thousand USD | 190243.94% |
| XOMA Corporation | 3.86 Million USD | -28208.547% |
| Nektar Therapeutics | 53.47 Million USD | -1943.818% |
| Arvinas, Inc. | 71.8 Million USD | -1422.274% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 1409.585% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 1841.128% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 339538.82% |
| Rezolute, Inc. | -36 Thousand USD | 3036191.667% |
| Clene Inc. | 533 Thousand USD | -204964.353% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 85124165.421% |
| BeyondSpring Inc. | 1.75 Million USD | -62321.074% |
| Synlogic, Inc. | -1.92 Million USD | 56908.368% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 2954135.135% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 17361.418% |
| Peak Bio, Inc. | 367.76 Thousand USD | -297095.522% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 5863.819% |
| Krystal Biotech, Inc. | 47.6 Million USD | -2195.963% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -674.672% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -21651.104% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 42313.231% |
| MannKind Corporation | 136.19 Million USD | -702.544% |
| Ikena Oncology, Inc. | -50.49 Million USD | 2264.685% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -904.46% |
| Gossamer Bio, Inc. | -4.38 Million USD | 25025.724% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 433827.381% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 21859960.0% |
| Legend Biotech Corporation | 140.92 Million USD | -675.563% |
| Mural Oncology plc | -2.56 Million USD | 42678.613% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 198465.336% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 1093093.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -5166.421% |
| REGENXBIO Inc. | 53.02 Million USD | -1961.123% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 20503.259% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 568257.505% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 63205.831% |
| Vaxart, Inc. | -60.76 Million USD | 1898.781% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 416034.622% |
| Cellectis S.A. | 18 Thousand USD | -6072083.333% |
| Longeveron Inc. | 221 Thousand USD | -494466.968% |
| Repare Therapeutics Inc. | -80.07 Million USD | 1465.047% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 84566.229% |
| Revolution Medicines, Inc. | -399.66 Million USD | 373.478% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 3122937.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -2230497.959% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 87.301% |
| Denali Therapeutics Inc. | -93.34 Million USD | 1270.918% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 4363519.697% |
| Veru Inc. | 7.56 Million USD | -14346.252% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 723936.424% |
| Cingulate Inc. | -582.91 Thousand USD | 187603.731% |
| Passage Bio, Inc. | -3.72 Million USD | 29473.636% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 9075100.0% |
| Exicure, Inc. | -1.42 Million USD | 76909.065% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 285476.762% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -40336.293% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 213294.129% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -1504.37% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 730676.109% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 1946.085% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -279437.852% |
| OmniAb, Inc. | 14.66 Million USD | -7352.056% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -5366.878% |
| Lipocine Inc. | -2.85 Million USD | 38439.627% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 59405.1% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 19258.51% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 72661.875% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -1351.21% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 1681627.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -1196.613% |
| Ocugen, Inc. | -33.53 Million USD | 3359.066% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 34666.509% |
| Q32 Bio Inc. | 578 Thousand USD | -188999.135% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 412550.189% |
| Alumis Inc. Common Stock | -1.28 Million USD | 85224.065% |
| Equillium, Inc. | 35.95 Million USD | -2939.638% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 64130.053% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -218202.146% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 26439214.659% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 422105.019% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -258466.826% |
| Dominari Holdings Inc. | 2.03 Million USD | -53504.365% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 595830.66% |
| vTv Therapeutics Inc. | -13.59 Million USD | 8139.669% |
| Bio-Techne Corporation | 773.07 Million USD | -41.383% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -6210.948% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -137.202% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 93598.118% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 4657.936% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -9244.216% |
| Nkarta, Inc. | -5.86 Million USD | 18723.156% |
| BioCardia, Inc. | -7.24 Million USD | 15177.845% |
| Iterum Therapeutics plc | -1.75 Million USD | 62556.743% |